COL5A2 and cancer: Unlike previously studied biomarkers such as TP53 or EGFR [11, 12], which have limitations in specificity due to their broader involvement in other cancer types and pathways, COL3A1, COL4A1, COL5A2, and CXCL8 appear to offer more targeted insights into the disease.